Sign Up to like & get
recommendations!
1
Published in 2022 at "Clinical and Translational Science"
DOI: 10.1111/cts.13313
Abstract: Remdesivir is the first US Food and Drug Administration (FDA)‐approved drug for the treatment of coronavirus disease 2019 (COVID‐19). We conducted a retrospective pharmacogenetic study to examine remdesivir‐associated liver enzyme elevation among Million Veteran Program…
read more here.
Keywords:
remdesivir associated;
liver enzyme;
associated liver;
program participants ... See more keywords